DE69730991D1 - Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung - Google Patents

Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung

Info

Publication number
DE69730991D1
DE69730991D1 DE69730991T DE69730991T DE69730991D1 DE 69730991 D1 DE69730991 D1 DE 69730991D1 DE 69730991 T DE69730991 T DE 69730991T DE 69730991 T DE69730991 T DE 69730991T DE 69730991 D1 DE69730991 D1 DE 69730991D1
Authority
DE
Germany
Prior art keywords
enterginal
alginsaure
coating containing
oral preparation
gelatine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69730991T
Other languages
English (en)
Other versions
DE69730991T2 (de
Inventor
Joern Marcussen
Erik Brandsborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deerland Probiotics and Enzymes AS
Original Assignee
Bifodan AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bifodan AS filed Critical Bifodan AS
Application granted granted Critical
Publication of DE69730991D1 publication Critical patent/DE69730991D1/de
Publication of DE69730991T2 publication Critical patent/DE69730991T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
DE69730991T 1996-06-06 1997-06-06 Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung Expired - Lifetime DE69730991T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK63696 1996-06-06
DK63696 1996-06-06
PCT/DK1997/000252 WO1997046224A1 (en) 1996-06-06 1997-06-06 Enteric coating, comprising alginic acid, for an oral preparation

Publications (2)

Publication Number Publication Date
DE69730991D1 true DE69730991D1 (de) 2004-11-04
DE69730991T2 DE69730991T2 (de) 2006-02-23

Family

ID=8095832

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69730991T Expired - Lifetime DE69730991T2 (de) 1996-06-06 1997-06-06 Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung

Country Status (14)

Country Link
US (1) US6455052B1 (de)
EP (1) EP0952824B1 (de)
JP (1) JP2000514406A (de)
KR (1) KR20000016331A (de)
CN (1) CN1147291C (de)
AT (1) ATE277605T1 (de)
AU (1) AU717817B2 (de)
BR (1) BR9709535A (de)
CA (1) CA2257378C (de)
DE (1) DE69730991T2 (de)
IL (1) IL127378A (de)
NO (1) NO327294B1 (de)
NZ (1) NZ333182A (de)
WO (1) WO1997046224A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3142821B2 (ja) * 1998-08-27 2001-03-07 株式会社エヌ・ティ・ティ・ドコモ 情報通信ネットワークの課金方法
JP3142820B2 (ja) * 1998-08-27 2001-03-07 株式会社エヌ・ティ・ティ・ドコモ プッシュ型情報配信方法およびその中継装置
AU2001296193B2 (en) * 2000-10-20 2006-04-27 Biovitrum Ab 2-, 3-, 4-, or 5-substituted-N1-(benzensulfonyl)indoles and their use in therapy
NL1018991C2 (nl) * 2001-09-20 2003-03-21 Tno Vochtwerende eetbare bekledingslaag voor voedingsmiddelen.
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
KR100491647B1 (ko) * 2002-11-21 2005-05-27 한국화학연구원 알긴산 나트륨 피복층을 포함하는 벤즈 이미다졸 유도체의경구체제 및 그의 제조방법
US7122370B2 (en) * 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
ATE387207T1 (de) * 2003-09-05 2008-03-15 Myung-Jun Chung Zweifach coating-beschichteten milchsäurenbakterienpulver mit protein und polysaccharid und das verfahren zur deren herstellung sowie deren dosisform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CN101257804A (zh) 2005-05-18 2008-09-03 帝斯曼知识产权资产管理有限公司 用于微生物的肠应用的组合物
US8343548B2 (en) * 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
US8519120B2 (en) 2006-08-08 2013-08-27 Shin-Etsu Chemical Co., Ltd. Methods for producing a low-substituted hydroxypropylcellulose powder
US8343547B2 (en) 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
JP2012502898A (ja) * 2008-09-17 2012-02-02 ハンター・イミュノロジー・リミテッド 分類不能（ｎｏｎ−ｔｙｐｅａｂｌｅ）インフルエンザ菌（Ｈａｅｍｏｐｈｉｌｕｓｉｎｆｌｕｅｎｚａｅ）ワクチンおよびその使用
CA2984935C (en) * 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
RU2567723C2 (ru) 2009-07-22 2015-11-10 Грюненталь Гмбх Стабильная при окислении, прочная на излом лекарственная форма
EP3202406A1 (de) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Präbiotische formulierungen und deren verwendungen
US8940858B2 (en) * 2010-05-17 2015-01-27 Northwestern University Fibrous microcapsules and methods of assembly and use thereof
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
DK2736497T3 (da) 2011-07-29 2017-11-13 Gruenenthal Gmbh Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
WO2013156453A1 (en) 2012-04-18 2013-10-24 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
WO2015153841A1 (en) 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
EP3142646A1 (de) 2014-05-12 2017-03-22 Grünenthal GmbH Manipulationssichere kapselformulierung mit tapentadol mit unmittelbarer freisetzung
JP6642438B2 (ja) * 2014-09-03 2020-02-05 ライオン株式会社 コーティング製剤及びその製造方法
ITUB20152290A1 (it) * 2015-07-17 2017-01-17 Laboratori Baldacci Spa Prodotto a base di ferro bisglicinato chelato e acido alginico e/o suoi sali idrosolubili, sue formulazioni ed suoi usi farmaceutici
US11865099B2 (en) 2015-07-17 2024-01-09 Laboratori Baldacci S.P.A. Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
KR20180093903A (ko) 2015-11-03 2018-08-22 더 브리검 앤드 우먼즈 하스피털, 인크. 음식 알레르기의 치료 및/또는 예방을 위한 치료용 미생물총
US20170296476A1 (en) * 2016-04-15 2017-10-19 Grünenthal GmbH Modified release abuse deterrent dosage forms
US10618042B1 (en) 2017-05-31 2020-04-14 University Of South Florida Mixed metal oxide extrudate catalyst
EP3723775A4 (de) 2017-12-15 2022-04-13 Solarea Bio, Inc. Mikrobielle zusammensetzungen und verfahren zur behandlung von typ-2-diabetes, fettleibigkeit und stoffwechselsyndrom
FR3083545A1 (fr) 2018-07-04 2020-01-10 Institut National De La Recherche Agronomique Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
EP3646857A1 (de) 2018-11-01 2020-05-06 Evonik Operations GmbH System zur abgabe von mikroorganismen im dickdarm
WO2020096992A1 (en) 2018-11-05 2020-05-14 MarvelBiome, Inc. Microbial compositions comprising ellagitannin and methods of use
CA3143713A1 (en) 2019-06-19 2020-12-24 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
WO2023006880A1 (en) * 2021-07-29 2023-02-02 Nutrition & Biosciences Usa 1, Llc Controlled release coating agent
WO2023092150A1 (en) 2021-11-22 2023-05-25 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE338976B (de) * 1970-01-29 1971-09-27 Foerenade Superfosfatfab Ab
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
CN1033441A (zh) * 1987-12-11 1989-06-21 福建省水产研究所 用褐藻胶制肠溶片剂的方法
CN1034489A (zh) * 1987-12-11 1989-08-09 福建省水产研究所 一种制作肠溶胶囊的方法
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5674495A (en) * 1995-02-27 1997-10-07 Purdue Research Foundation Alginate-based vaccine compositions
US5882715A (en) * 1995-06-20 1999-03-16 Pharma-Vinci A/S Method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method

Also Published As

Publication number Publication date
NO985699L (no) 1999-02-08
US6455052B1 (en) 2002-09-24
NO327294B1 (no) 2009-06-02
DE69730991T2 (de) 2006-02-23
CN1147291C (zh) 2004-04-28
NZ333182A (en) 2000-03-27
AU3026397A (en) 1998-01-05
CA2257378C (en) 2009-04-07
JP2000514406A (ja) 2000-10-31
IL127378A0 (en) 1999-10-28
BR9709535A (pt) 2000-01-11
IL127378A (en) 2003-07-31
AU717817B2 (en) 2000-04-06
EP0952824A1 (de) 1999-11-03
CN1223573A (zh) 1999-07-21
KR20000016331A (ko) 2000-03-25
ATE277605T1 (de) 2004-10-15
CA2257378A1 (en) 1997-12-11
WO1997046224A1 (en) 1997-12-11
NO985699D0 (no) 1998-12-04
EP0952824B1 (de) 2004-09-29

Similar Documents

Publication Publication Date Title
DE69730991D1 (de) Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung
NO870558D0 (no) Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat.
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
EA200401086A1 (ru) Жевательная резинка с покрытием, содержащая активное вещество системного действия
DK13491D0 (da) Anvendelse af et enzymholdigt granulat og fremgangsmaade til fremstilling af et forderstof i tabletform
HUP0003990A2 (en) Methods of treating capsules and dry, powdered pharmaceutical formulations
DE59812646D1 (de) Laminare Arzneiform
DK495884A (da) Shellakindkapslingsmiddel til aktive bestanddele i tyggegummi
ATE297223T1 (de) Teilchenförmige vitaminzubereitung
ATE271854T1 (de) Acetaminophen-formulierung mit verlängerter freisetzung
CA2339931A1 (en) Extended release acetaminophen
TR199802670T2 (xx) Pestisidal tablet form�lasyonlar�.
DE69101490T2 (de) Verfahren zum Einbauen in Pellets von gegen Abbau im Pansen von Wiederkäuern geschützten Wirkstoffen.
DE69813846D1 (de) Geschmacksmaskierung schlecht schmeckender formulierungen
UA39899C2 (uk) Спосіб приготування сухого сипучого порошку ацифлуорфену або його агротехнічно придатних солей (варіанти), приготований таким способом сухий сипучий порошок (варіанти) та пва-пакет, що містить cухий сипучий порошок (варіанти)
NO167813C (no) Fremgangsmaate for fremstilling av carboxylgruppeholdige polyamider, og anvendelse av disse som lakkbindemiddel.
JPS54129130A (en) Method for promoting roughage digestion of animal
IL74956A0 (en) N-(3-phenylmethyl thio-1-oxopropyl)aminoacetic acid derivatives,their preparation and pharmaceutical compositions containing them
ES2164566A1 (es) Preparacion cosmetica o dermofarmaceutica compuesta de milicapsulas conrecubrimiento de polisacaridos cationicos.
JPS5573608A (en) Stable diagnosing drug for radioactive technetium labeling
ZA852923B (en) N-(3-phenylmethylthio-1-oxoporpyl)aminoacetic acid derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition